David Moher
Impact in
- Statistics, Probability and Uncertainty top 0.01%
- Meta-analysis and systematic reviews
- Health Informatics top 0.01%
Papers in
-
- Meta-analysis and systematic reviews 619
- scientometrics and bibliometrics research 38
-
- Academic Publishing and Open Access 88
- Co-authors
- Douglas G. Altman (165 shared papers)Alessandro Liberati (18 shared papers)Jennifer Tetzlaff (33 shared papers)Kenneth F. Schulz (90 shared papers)Peter Christian Gøtzsche (15 shared papers)Mike J Clarke (18 shared papers)Philip James Devereaux (9 shared papers)John P. A. Ioannidis (30 shared papers)
- Journals
- Journal of Clinical Epidemiology (102 papers)Systematic Reviews (70 papers)BMJ (48 papers)BMJ Open (35 papers)PLoS ONE (31 papers)
- Partner nations
- CanadaUnited KingdomUnited States
In The Last Decade
David Moher
962 papers receiving 689.6k citations
David Moher's Hit Papers
Peers
Comparison fields: 5 of 244
- Statistics, Probability and Uncertainty 47.5k
- Health Informatics 5.4k
- Complementary and alternative medicine 16.3k
- General Health Professions 38.1k
- Psychiatry and Mental health 27k
Countries citing papers authored by David Moher
This map shows the geographic impact of David Moher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Moher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Moher more than expected).
Fields of papers citing papers by David Moher
This network shows the impact of papers produced by David Moher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Moher. The network helps show where David Moher may publish in the future.
Co-authors
The 25 scholars most cited alongside David Moher, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 990 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Hit paper breakdown → | 2009 | 75636 |
| 2 | The PRISMA 2020 statement: an updated guideline for reporting systematic reviews Hit paper breakdown → | 2021 | 69848 |
| 3 | Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement Hit paper breakdown → | 2009 | 54916 |
| 4 | Preferred reporting items for systematic reviews and meta-analyses: the PRISMA Statement. Hit paper breakdown → | 2009 | 43661 |
| 5 | Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement Hit paper breakdown → | 2009 | 32575 |
| 6 | PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation Hit paper breakdown → | 2018 | 28309 |
| 7 | The Cochrane Collaboration's tool for assessing risk of bias in randomised trials Hit paper breakdown → | 2011 | 28150 |
| 8 | The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration Hit paper breakdown → | 2009 | 25128 |
| 9 | Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement Hit paper breakdown → | 2015 | 20681 |
| 10 | Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement Hit paper breakdown → | 2009 | 16493 |
| 11 | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration Hit paper breakdown → | 2009 | 15309 |
| 12 | CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials Hit paper breakdown → | 2010 | 11709 |
| 13 | The PRISMA 2020 statement: an updated guideline for reporting systematic reviews Hit paper breakdown → | 2021 | 11164 |
| 14 | Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement Hit paper breakdown → | 2010 | 10447 |
| 15 | Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation Hit paper breakdown → | 2015 | 10436 |
| 16 | The PRISMA 2020 statement: An updated guideline for reporting systematic reviews Hit paper breakdown → | 2021 | 9423 |
| 17 | The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration Hit paper breakdown → | 2009 | 9248 |
| 18 | The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration Hit paper breakdown → | 2009 | 8775 |
| 19 | PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews Hit paper breakdown → | 2021 | 8260 |
| 20 | AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both Hit paper breakdown → | 2017 | 7724 |
About David Moher
David Moher is a scholar working on Statistics, Probability and Uncertainty, Information Systems and Management, History and Philosophy of Science, Statistics and Probability and Complementary and alternative medicine, having authored 990 papers that have together received 706k indexed citations. Recurring topics across this work include Meta-analysis and systematic reviews (619 papers), Academic Publishing and Open Access (88 papers), Statistical Methods in Clinical Trials (53 papers), Publishing and Scholarly Communication (50 papers), Research Data Management Practices (39 papers), scientometrics and bibliometrics research (38 papers), Academic Writing and Publishing (32 papers) and Pharmaceutical industry and healthcare (24 papers). The work is most often cited by research in Statistics, Probability and Uncertainty (47.5k citations), Health Informatics (5.4k citations), Complementary and alternative medicine (16.3k citations), General Health Professions (38.1k citations) and Psychiatry and Mental health (27k citations). David Moher has collaborated with scholars based in Canada, United Kingdom and United States. Frequent co-authors include Douglas G. Altman, Alessandro Liberati, Jennifer Tetzlaff, Kenneth F. Schulz, Peter Christian Gøtzsche, Mike J Clarke, Philip James Devereaux, John P. A. Ioannidis, Cynthia D. Mulrow and Jos Kleijnen. Their work appears in journals such as Journal of Clinical Epidemiology, Systematic Reviews, BMJ, BMJ Open and PLoS ONE.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.